STOCK TITAN
  1. Home
  2. News
  3. LLY

Lilly(Eli) & Co - LLY STOCK NEWS

IMPACT
SENTIMENT
LLY : NYSE
Lilly's tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks
IMPACT
SENTIMENT
LLY : NYSE
Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial
clinical trial
IMPACT
SENTIMENT
LLY : NYSE
Lilly Announces Details of Presentations at ESMO Congress 2023
IMPACT
SENTIMENT
LLY : NYSE
Loxo@Lilly Unveils Three New Oncology Programs at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
IMPACT
SENTIMENT
LLY : NYSE
Lilly Announces Leadership Transitions
management
IMPACT
SENTIMENT
LLY : NYSE PNT : Nasdaq
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies
acquisition
IMPACT
SENTIMENT
LLY : NYSE
U.S. Food and Drug Administration Issues Complete Response Letter for Lebrikizumab Based on Inspection Findings at Third-Party Manufacturer
IMPACT
SENTIMENT
LLY : NYSE
US FDA approves Jardiance® for the treatment of adults with chronic kidney disease
fda approval
IMPACT
SENTIMENT
LLY : NYSE
Lilly's Retevmo® (selpercatinib) Demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer
IMPACT
SENTIMENT
LLY : NYSE
Lilly Completes Acquisition of Versanis Bio
acquisition
Stock LLY logo
Lilly(Eli) & Co
NYSE:LLY

LLY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About LLY

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.